Developer docs
API playgroundTry for free, no card

Search company profiles

Aphea.Bio

Full company profile

uuid0000r1m

Namestring
Aphea.Bio
Legal namestring
Aphea.Bio NV
Websiteurl
aphea.bio
Company typeenum
Private
Founded yearint
2017
Descriptiontext

Aphea.Bio NV is a Belgian agricultural biologicals company, founded in July 2017 as a spin-off of VIB, Ghent University, and KU Leuven, headquartered at the Technologiepark bio-accelerator in Zwijnaarde (Ghent). The company discovers and develops microbial-based crop inputs — biostimulants (ACTIV by Aphea.Bio for wheat, INITIA for maize) and biocontrol products (biofungicides VALORIA for wheat and VIRTUOSA for fruit and vegetables, with bioinsecticides and bioherbicides in the pipeline) — for conventional and sustainable agriculture. Its discovery engine is the proprietary APEXbio platform, a high-throughput pipeline combining bioinformatics, microbiome mapping, microbial culturing, automated crop phenotyping, and data analysis to screen more than 100,000 microbial strains drawn from a proprietary library of 15,000+ isolates. A second platform, TRΛNSCEND (launched September 2025 under a VLAIO grant), extends discovery to bioactive compounds from Microbial Natural Products.

The company's business model is B2B and asset-light on direct sales: commercial products are distributed through exclusive channel partnerships — ACTIV is sold across multiple European countries via Syngenta Crop Protection (initial launch Poland, June 2023) and the bioinsecticide program is co-developed with Bayer Crop Science under a partnership signed in June 2026 — generating a mix of licensing/royalty, co-development milestones, and product sales. Pricing is not publicly disclosed and is set via individual B2B agreements. Operations are anchored in Belgium, with a pilot-scale production facility inaugurated in 2023, ~65 employees as of 2025, and ~€97.5M of cumulative equity funding (Series A €7.7M 2017, Series B €19.8M 2020, Series C €70M 2023 led by Innovation Industries with Bill & Melinda Gates Foundation participation). Revenue is not publicly disclosed; ACTIV is the only product in commercial distribution, while VALORIA and VIRTUOSA are pending US EPA registration.

Short descriptiontext

Aphea.Bio NV is a Belgian agricultural biologicals company developing microbial-based biostimulants and biocontrol products (biofungicides, bioinsecticides, bioherbicides) for sustainable crop protection, discovered through its proprietary APEXbio and TRΛNSCEND R&D platforms and commercialized via channel partners including Syngenta and Bayer.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersZwijnaarde, Belgium
HQ citystring
Zwijnaarde
HQ countrystring
Belgium
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
biological crop protection, agricultural biostimulants, biofungicide products, microbial strain discovery, sustainable agriculture solutions
Industry3 codes
PRIMARYAFABAEAK
Biostimulants & Plant Health Biologicals (Microbial/Non-microbial)
Agriculture & Food Production/Agricultural Inputs & Agrochemicals/Biologicals & Biopesticides (Microbials, Botanicals, Beneficial Insects)
SECONDARYEUAAAIAL
Enzymes & Industrial Biotechnology Inputs (Enzymes, Microbial Strains, Fermentation Aids)
Energy, Utilities & Environment/Bioenergy, Natural Gas & Biomass/Biorefining & Bio-based Chemicals (Co-products, Bioproducts)
SECONDARYHLAAAFAJ
Microbiome Manufacturing, Formulation & Delivery Technologies (encapsulation, spores, oral delivery)
NAICS code2 codes
  • Pesticide, Fertilizer, and Other Agricultural Chemical Manufacturing3253
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
SIC code2 codes
  • Agricultural Chemicals2870
  • Biological Products, (No Disgnostic Substances)2836
Product category
Agricultural Biologicals
Social media profiles2 records
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model4 records
1Biostimulant Products
TypeOne Time License
Description

Revenue from sale of microbial-based biostimulant products for seed treatment. First commercial product ACTIV launched in Poland in 2023 for wheat; INITIA for maize in development with expansion plans to US and Brazil markets.

aphea.bio
2Biofungicide Products
TypeOne Time License
Description

Revenue from sale of biofungicide products VALORIA for wheat and VIRTUOSA for fruit and vegetables. Products pending EPA registration in US.

aphea.bio
3Bioinsecticide Development
TypeLicensing Royalties
Description

Revenue potential from bioinsecticide products developed through Bayer partnership. Partnership leverages Aphea.Bio's R&D pipeline alongside Bayer's global market reach.

belganewsagency.eu
4Licensing and Co-development
TypeLicensing Royalties
Description

Strategic partnerships including Syngenta collaboration for wheat biostimulant across multiple European countries, generating licensing and co-development revenue.

aphea.bio
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 5 records shown
1ACTIV by Aphea.Bio
Description

Biostimulant seed treatment for wheat providing consistent yield increase under reduced fertilization

aphea.bio
+4 more records
Core offering1 text field

Aphea.Bio develops and commercializes microbial-based biostimulant and biocontrol products for sustainable agriculture. Its commercial portfolio includes two biostimulant seed treatments (ACTIV for wheat, INITIA for maize) and two biofungicides (VALORIA for wheat, VIRTUOSA for fruit and vegetables), with additional bioinsecticide and bioherbicide candidates in the pipeline. All products are derived from the company's proprietary APEXbio R&D platform that screens naturally occurring microorganisms for crop-enhancing and crop-protecting applications.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • 5% yield increase (250 kg/ha additional) with ACTIV biostimulant under reduced fertilization
+4 more records
Product overview1 text field

Aphea.Bio is a biologicals company developing and commercializing biostimulant and biocontrol products for agriculture. The product portfolio consists of two biostimulant seed treatments (ACTIV by Aphea.Bio™ for wheat and INITIA by Aphea.Bio™ for maize) and two biofungicides submitted for regulatory approval (VALORIA™ for wheat and VIRTUOSA™ for fruit and vegetables). The company also maintains a rich pipeline of bioinsecticide and bioherbicide candidates. All products are developed using the proprietary APEXbio™ R&D platform, which screens microbial strains to identify beneficial microorganisms for crop enhancement and protection.

Product and service4 records
1ACTIV by Aphea.Bio
CategoryBiostimulant Seed Treatment
Description

A biostimulant seed treatment for wheat based on a proprietary strain of Stenotrophomonas rhizophila. Improves nutrient uptake, enables up to 5% higher yields even with reduced fertilizer use, and enhances crop performance under stress conditions such as drought and salinity. Distributed through Syngenta Crop Protection in Europe.

2INITIA by Aphea.Bio
CategoryBiostimulant Seed Treatment
Description

A biostimulant designed for maize seed treatment, enhancing germination, early vigour, root biomass, and nutrient use efficiency (nitrogen and phosphorus). Demonstrated robust yield increases under both reduced and full fertilization conditions in EU field trials, with planned market expansion to US and Brazil.

3VALORIA
CategoryBiofungicide
Description

A foliar biofungicide for wheat based on a Streptomyces strain. Offers broad-spectrum activity protecting against head blight, yellow rust, leaf blotch, and powdery mildew. Features two-year shelf life at ambient temperatures and compatibility with standard agricultural chemicals. Pending EPA registration in the US.

4VIRTUOSA
CategoryBiofungicide
Description

A foliar biofungicide for fruit and vegetables based on a Streptomyces strain. Provides broad-spectrum protection against diseases such as grey mold and powdery mildew. Easy-to-use liquid formulation with long shelf life, suitable for Integrated Pest Management programs. Pending EPA registration in the US.

Scale indicator15 records

Each record includes

Type, Value, Description, Source

Partnership5 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-06-10
Description

Strategic partnership with Bayer Crop Science to develop biological insecticides targeting sap-sucking insects in agriculture. Leverages Aphea.Bio's R&D pipeline alongside Bayer's global market reach and large-scale product development capacity. Initially targeting fruit crops (citrus, grapes, pome, stone) with potential expansion to vegetables and row crops (cotton, soybean). Partnership formalized at signing ceremony in Monheim on June 9, 2026.

Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2023-03-01
Description

Collaboration to accelerate introduction of novel biological seed treatment solution (ΛCTIV) across multiple countries in Europe over five years, pending regulatory approval. Syngenta Polska hosted exclusive launch event on June 5, 2023 for Polish market introduction. Market introductions in additional countries prepared for 2024.

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2017-07-01
Description

Aphea.Bio founded as VIB spin-off in July 2017. VIB is a life science research organization; Johan Cardoen served as managing director from 2012-2020. Willem Broekaert represents V-Bio Ventures as Board Observer.

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2017-07-01
Description

University partner in founding spin-off from VIB. Contributed to company's scientific foundation and ongoing research capabilities.

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2017-07-01
Description

University partner in founding spin-off from VIB. Contributed to company's scientific foundation.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

US-based agricultural biotech using a proprietary microbial strain library and high-throughput screening platform (Genesis) to discover biocontrol and biostimulant products. Closely comparable discovery engine, target customer (row crop and specialty growers), and biological crop protection focus.

TypeDirect peer
Description

US agricultural biologicals company developing microbial seed treatments and biostimulants for major row crops. Comparable product format (seed-applied biologicals), target crops (wheat, maize), and go-to-market with ag-input retailers and partners.

TypeDirect peer
Description

US microbial nitrogen-fixing company with Proven® seed treatment and Proven® G3 for cereals including wheat. Direct comparable on microbial seed treatment technology, row crop focus, and partnership-driven distribution model.

TypeDirect peer
Description

Belgian biocontrol company specializing in biological crop protection including bumblebee pollination, beneficial insects, and microbial products. Same HQ country (Belgium), same biological crop protection category, and overlapping high-value crop (fruit and vegetables) focus.

TypeDirect peer
Description

US ag biotech with bioinspired nutrient efficiency products for row crops. Comparable in microbial and biochemical product development for nutrient use efficiency, targeting similar wheat, corn, and soybean growers.

TypeDirect peer
Description

Argentina-based agricultural biologicals company with biostimulant and biofungicide products (e.g., Rizoderma, Trichoderma) for row crops including wheat and soybeans. Comparable biological portfolio, Latin American market overlap (Aphea.Bio plans INITIA in Brazil), and partner-distribution strategy.

TypeBroad incumbent
Description

Global market leader in enzymes and microbial solutions formed by the Novozymes-Chr. Hansen merger. Comparable broad portfolio of agricultural biologicals and biocontrol, but much larger scale, broader industrial focus, and serves many end markets beyond agriculture.

TypeBroad incumbent
Description

One of the world's largest crop protection and seed companies, currently a strategic development partner to Aphea.Bio for bioinsecticides. Overlapping capabilities in biologicals (BioAct, Serenade) alongside synthetic chemistry and seeds. Not a direct competitor in Aphea.Bio's narrow microbial niche but rapidly expanding into biologicals.

TypeBroad incumbent
Description

Global ag-input giant currently a strategic distribution partner for ACTIV across Europe. Sells its own biostimulant and biological portfolio alongside conventional chemistry. Comparable broad crop protection portfolio but operates at vastly greater scale and across all input categories.

TypeEmerging player
Description

US synthetic biology platform company with an agricultural biologicals arm (formerly Joyn Bio with Bayer, now Ginkgo Ag). Comparable in using high-throughput microbial engineering and screening, but operates across many end markets (pharma, food, industrial) with agriculture as one application area.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment7 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles8 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds5 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors17 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Aphea.Bio

Agricultural Biologicalsaphea.bio

Aphea.Bio NV is a Belgian agricultural biologicals company developing microbial-based biostimulants and biocontrol products (biofungicides, bioinsecticides, bioherbicides) for sustainable crop protection, discovered through its proprietary APEXbio and TRΛNSCEND R&D platforms and commercialized via channel partners including Syngenta and Bayer.

What Aphea.Bio does

Aphea.Bio NV is a Belgian agricultural biologicals company, founded in July 2017 as a spin-off of VIB, Ghent University, and KU Leuven, headquartered at the Technologiepark bio-accelerator in Zwijnaarde (Ghent). The company discovers and develops microbial-based crop inputs — biostimulants (ACTIV by Aphea.Bio for wheat, INITIA for maize) and biocontrol products (biofungicides VALORIA for wheat and VIRTUOSA for fruit and vegetables, with bioinsecticides and bioherbicides in the pipeline) — for conventional and sustainable agriculture. Its discovery engine is the proprietary APEXbio platform, a high-throughput pipeline combining bioinformatics, microbiome mapping, microbial culturing, automated crop phenotyping, and data analysis to screen more than 100,000 microbial strains drawn from a proprietary library of 15,000+ isolates. A second platform, TRΛNSCEND (launched September 2025 under a VLAIO grant), extends discovery to bioactive compounds from Microbial Natural Products.

The company's business model is B2B and asset-light on direct sales: commercial products are distributed through exclusive channel partnerships — ACTIV is sold across multiple European countries via Syngenta Crop Protection (initial launch Poland, June 2023) and the bioinsecticide program is co-developed with Bayer Crop Science under a partnership signed in June 2026 — generating a mix of licensing/royalty, co-development milestones, and product sales. Pricing is not publicly disclosed and is set via individual B2B agreements. Operations are anchored in Belgium, with a pilot-scale production facility inaugurated in 2023, ~65 employees as of 2025, and ~€97.5M of cumulative equity funding (Series A €7.7M 2017, Series B €19.8M 2020, Series C €70M 2023 led by Innovation Industries with Bill & Melinda Gates Foundation participation). Revenue is not publicly disclosed; ACTIV is the only product in commercial distribution, while VALORIA and VIRTUOSA are pending US EPA registration.

Aphea.Bio firmographics

Firmographics
Name
Aphea.Bio
Legal name
Aphea.Bio NV
Website
https://aphea.bio
Company type
Private
Founded year
2017
Operating status
Operating
Headcount range
51–100 employees
Short description
Aphea.Bio NV is a Belgian agricultural biologicals company developing microbial-based biostimulants and biocontrol products (biofungicides, bioinsecticides, bioherbicides) for sustainable crop protection, discovered through its proprietary APEXbio and TRΛNSCEND R&D platforms and commercialized via channel partners including Syngenta and Bayer.
Ownership category
akta.pro rank

Aphea.Bio industry classification

Industry
Product category
Agricultural Biologicals
NAICS
Pesticide, Fertilizer, and Other Agricultural Chemical Manufacturing (3253), Research and Development in Biotechnology (except Nanobiotechnology) (541714)
SIC
Agricultural Chemicals (2870), Biological Products, (No Disgnostic Substances) (2836)
akta.pro industry
PRIMARYAFABAEAK
Biostimulants & Plant Health Biologicals (Microbial/Non-microbial)
Agriculture & Food Production/Agricultural Inputs & Agrochemicals/Biologicals & Biopesticides (Microbials, Botanicals, Beneficial Insects)
SECONDARYEUAAAIAL
Enzymes & Industrial Biotechnology Inputs (Enzymes, Microbial Strains, Fermentation Aids)
Energy, Utilities & Environment/Bioenergy, Natural Gas & Biomass/Biorefining & Bio-based Chemicals (Co-products, Bioproducts)
SECONDARYHLAAAFAJ
Microbiome Manufacturing, Formulation & Delivery Technologies (encapsulation, spores, oral delivery)

Keywords

  • Biological crop protection
  • Agricultural biostimulants
  • Biofungicide products
  • Microbial strain discovery
  • Sustainable agriculture solutions

Where Aphea.Bio is headquartered

Location

Headquarters

HQ city
Zwijnaarde
HQ country
Belgium
HQ region
Europe

Offices1 record

Markets served

Aphea.Bio business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure

Revenue model

  1. Biostimulant Products: Revenue from sale of microbial-based biostimulant products for seed treatment. First commercial product ACTIV launched in Poland in 2023 for wheat; INITIA for maize in development with expansion plans to US and Brazil markets.
  2. Biofungicide Products: Revenue from sale of biofungicide products VALORIA for wheat and VIRTUOSA for fruit and vegetables. Products pending EPA registration in US.
  3. Bioinsecticide Development: Revenue potential from bioinsecticide products developed through Bayer partnership. Partnership leverages Aphea.Bio's R&D pipeline alongside Bayer's global market reach.
  4. Licensing and Co-development: Strategic partnerships including Syngenta collaboration for wheat biostimulant across multiple European countries, generating licensing and co-development revenue.

Go-to-market motion2 records

Distribution channels4 records

Marketing channels6 records

Aphea.Bio product offering

Product offering

Core offering

Aphea.Bio develops and commercializes microbial-based biostimulant and biocontrol products for sustainable agriculture. Its commercial portfolio includes two biostimulant seed treatments (ACTIV for wheat, INITIA for maize) and two biofungicides (VALORIA for wheat, VIRTUOSA for fruit and vegetables), with additional bioinsecticide and bioherbicide candidates in the pipeline. All products are derived from the company's proprietary APEXbio R&D platform that screens naturally occurring microorganisms for crop-enhancing and crop-protecting applications.

Product overview

Aphea.Bio is a biologicals company developing and commercializing biostimulant and biocontrol products for agriculture. The product portfolio consists of two biostimulant seed treatments (ACTIV by Aphea.Bio™ for wheat and INITIA by Aphea.Bio™ for maize) and two biofungicides submitted for regulatory approval (VALORIA™ for wheat and VIRTUOSA™ for fruit and vegetables). The company also maintains a rich pipeline of bioinsecticide and bioherbicide candidates. All products are developed using the proprietary APEXbio™ R&D platform, which screens microbial strains to identify beneficial microorganisms for crop enhancement and protection.

Differentiator

Problem solved

Functional benefit

Brands

  • ACTIV by Aphea.Bio: Biostimulant seed treatment for wheat providing consistent yield increase under reduced fertilization
  • INITIA by Aphea.Bio
  • VALORIA
  • VIRTUOSA
  • APEXbio

Products and services

  • ACTIV by Aphea.Bio A biostimulant seed treatment for wheat based on a proprietary strain of Stenotrophomonas rhizophila. Improves nutrient uptake, enables up to 5% higher yields even with reduced fertilizer use, and enhances crop performance under stress conditions such as drought and salinity. Distributed through Syngenta Crop Protection in Europe.
  • INITIA by Aphea.Bio A biostimulant designed for maize seed treatment, enhancing germination, early vigour, root biomass, and nutrient use efficiency (nitrogen and phosphorus). Demonstrated robust yield increases under both reduced and full fertilization conditions in EU field trials, with planned market expansion to US and Brazil.
  • VALORIA A foliar biofungicide for wheat based on a Streptomyces strain. Offers broad-spectrum activity protecting against head blight, yellow rust, leaf blotch, and powdery mildew. Features two-year shelf life at ambient temperatures and compatibility with standard agricultural chemicals. Pending EPA registration in the US.
  • VIRTUOSA A foliar biofungicide for fruit and vegetables based on a Streptomyces strain. Provides broad-spectrum protection against diseases such as grey mold and powdery mildew. Easy-to-use liquid formulation with long shelf life, suitable for Integrated Pest Management programs. Pending EPA registration in the US.

Quantifiable outcome

  • 5% yield increase (250 kg/ha additional) with ACTIV biostimulant under reduced fertilization
  • +4 more outcomes

Companies that use Aphea.Bio

Customer profile

Named customers2 records

Segments7 records

Ideal customer profiles3 records

Aphea.Bio technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature5 records

Aphea.Bio partnerships and signals

Strategic signal

Partnerships

Five partnerships are on record, tiered core.

  • BayercoreStrategic or Co-development Partner · 10 June 2026Strategic partnership with Bayer Crop Science to develop biological insecticides targeting sap-sucking insects in agriculture. Leverages Aphea.Bio's R&D pipeline alongside Bayer's global market reach and large-scale product development capacity. Initially targeting fruit crops (citrus, grapes, pome, stone) with potential expansion to vegetables and row crops (cotton, soybean). Partnership formalized at signing ceremony in Monheim on June 9, 2026.
  • Syngenta Crop ProtectioncoreChannel Partner/ Reseller/ Distributor · 1 March 2023Collaboration to accelerate introduction of novel biological seed treatment solution (ΛCTIV) across multiple countries in Europe over five years, pending regulatory approval. Syngenta Polska hosted exclusive launch event on June 5, 2023 for Polish market introduction. Market introductions in additional countries prepared for 2024.
  • VIB (Flemish Institute for Biotechnology)coreTechnology or Integration · 1 July 2017Aphea.Bio founded as VIB spin-off in July 2017. VIB is a life science research organization; Johan Cardoen served as managing director from 2012-2020. Willem Broekaert represents V-Bio Ventures as Board Observer.
  • Ghent UniversitycoreTechnology or Integration · 1 July 2017University partner in founding spin-off from VIB. Contributed to company's scientific foundation and ongoing research capabilities.
  • KU LeuvencoreTechnology or Integration · 1 July 2017University partner in founding spin-off from VIB. Contributed to company's scientific foundation.

Scale indicators15 records

Recent moves7 records

Expansion highlights6 records

Aphea.Bio competitors and assessment

Company assessment

Direct peers

  • AgBiome: US-based agricultural biotech using a proprietary microbial strain library and high-throughput screening platform (Genesis) to discover biocontrol and biostimulant products. Closely comparable discovery engine, target customer (row crop and specialty growers), and biological crop protection focus.
  • Indigo Ag: US agricultural biologicals company developing microbial seed treatments and biostimulants for major row crops. Comparable product format (seed-applied biologicals), target crops (wheat, maize), and go-to-market with ag-input retailers and partners.
  • Pivot Bio: US microbial nitrogen-fixing company with Proven® seed treatment and Proven® G3 for cereals including wheat. Direct comparable on microbial seed treatment technology, row crop focus, and partnership-driven distribution model.
  • Biobest Group: Belgian biocontrol company specializing in biological crop protection including bumblebee pollination, beneficial insects, and microbial products. Same HQ country (Belgium), same biological crop protection category, and overlapping high-value crop (fruit and vegetables) focus.
  • Sound Agriculture: US ag biotech with bioinspired nutrient efficiency products for row crops. Comparable in microbial and biochemical product development for nutrient use efficiency, targeting similar wheat, corn, and soybean growers.
  • Bioceres Crop Solutions: Argentina-based agricultural biologicals company with biostimulant and biofungicide products (e.g., Rizoderma, Trichoderma) for row crops including wheat and soybeans. Comparable biological portfolio, Latin American market overlap (Aphea.Bio plans INITIA in Brazil), and partner-distribution strategy.

Broad incumbents

  • Novonesis (Novozymes): Global market leader in enzymes and microbial solutions formed by the Novozymes-Chr. Hansen merger. Comparable broad portfolio of agricultural biologicals and biocontrol, but much larger scale, broader industrial focus, and serves many end markets beyond agriculture.
  • Bayer Crop Science: One of the world's largest crop protection and seed companies, currently a strategic development partner to Aphea.Bio for bioinsecticides. Overlapping capabilities in biologicals (BioAct, Serenade) alongside synthetic chemistry and seeds. Not a direct competitor in Aphea.Bio's narrow microbial niche but rapidly expanding into biologicals.
  • Syngenta Crop Protection: Global ag-input giant currently a strategic distribution partner for ACTIV across Europe. Sells its own biostimulant and biological portfolio alongside conventional chemistry. Comparable broad crop protection portfolio but operates at vastly greater scale and across all input categories.

Emerging players

  • Ginkgo Bioworks: US synthetic biology platform company with an agricultural biologicals arm (formerly Joyn Bio with Bayer, now Ginkgo Ag). Comparable in using high-throughput microbial engineering and screening, but operates across many end markets (pharma, food, industrial) with agriculture as one application area.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Aphea.Bio social profiles

Digital presence

Aphea.Bio compliance and trust

Trust signal

Compliance3 records

Aphea.Bio financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Aphea.Bio leadership team

Management profile

Number of profiles

Profiles8 records

Aphea.Bio funding detail

Funding detail

Funding overview

Funding rounds5 records

Investors17 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Aphea.Bio M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Aphea.Bio

What does Aphea.Bio do?

Aphea.Bio develops and commercializes microbial-based biostimulant and biocontrol products for sustainable agriculture. Its commercial portfolio includes two biostimulant seed treatments (ACTIV for wheat, INITIA for maize) and two biofungicides (VALORIA for wheat, VIRTUOSA for fruit and vegetables), with additional bioinsecticide and bioherbicide candidates in the pipeline. All products are derived from the company's proprietary APEXbio R&D platform that screens naturally occurring microorganisms for crop-enhancing and crop-protecting applications.

Is Aphea.Bio a public or private company?

Aphea.Bio is a private company. It is classified as venture growth investor backed and is currently operating.

When was Aphea.Bio founded?

Aphea.Bio was founded in 2017. It employs 51 to 100 people.

Where is Aphea.Bio based?

Aphea.Bio is headquartered in Zwijnaarde, Belgium, in the Europe region.

How does Aphea.Bio make money?

Four revenue lines are on record. Biostimulant Products are the primary driver. The others are biofungicide Products, bioinsecticide Development and licensing and Co-development.

Who are Aphea.Bio's main competitors?

Direct peers on record are AgBiome, Indigo Ag, Pivot Bio, Biobest Group, Sound Agriculture and Bioceres Crop Solutions. Broad incumbents are Novonesis (Novozymes), Bayer Crop Science and Syngenta Crop Protection. Ginkgo Bioworks is listed as an emerging player.

Does Aphea.Bio have an API?

No public API is recorded for Aphea.Bio.

What industry is Aphea.Bio in?

Aphea.Bio's product category is Agricultural Biologicals. Its primary akta.pro industry code is AFABAEAK, Biostimulants & Plant Health Biologicals (Microbial/Non-microbial), with a secondary code of EUAAAIAL, Enzymes & Industrial Biotechnology Inputs (Enzymes, Microbial Strains, Fermentation Aids). Its NAICS code is 3253 and its SIC code is 2870.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
AgnavigatorBayer-Aphea.Bio deal targets next-gen bioinsecticides as ag majors continue biologicals pushBayer and Aphea.Bio signed a research partnership to co-develop bioinsecticides targeting sap-sucking insects, focusing on fruit crops. The deal combines Aphea.Bio's microbial metabolites with Bayer's development capabilities, reflecting a broader industry shift toward biologicals. Bayer faces around 100,000 glyphosate-related claims, but the partnership aims to diversify into lower-risk crop protection.SilverwoodpartnersConsumer Private Placement and M&A Transactions Review Week Ending July 23, 2023A Pitchbook data review of consumer private placement and M&A transactions for the week ending July 23, 2023 lists several financing rounds, including Aphea.Bio's EUR 70 million Series C, Bobbie's $70 million Series C at a $500 million pre-money valuation, and ZenWTR's $35.9 million round. M&A activity included La Colombe Coffee Roasters' $300 million stake from Keurig Dr Pepper and multiple LBOs.FinSMEsAphea.Bio Raises € 70M in Series C FundingBelgium-based agricultural technology company Aphea.Bio has raised €70 million in Series C funding led by Innovation Industries with participation from the Bill & Melinda Gates Foundation and other investors. The company plans to utilize these funds to advance research and development in biologicals, scale product launches, and expand its commercial reach. A key strategic outcome of this round is a partnership with the Gates Foundation to develop biostimulant products for smallholder farmers in Sub-Saharan Africa and South Asia.BufferBacked by the Bill & Melinda Gates Foundation and others, Belgian agtech firm Aphea.bio raises €70 millionBelgian agtech firm Aphea.bio has closed a €70 million Series C funding round led by Innovation Industries, with participation from the Bill & Melinda Gates Foundation and other investors. The capital will be used to expand research facilities, including a new pilot plant, and to develop biostimulant products for smallholder farmers in Sub-Saharan Africa and South Asia.ImpactalphaAphea.Bio secures €14 million to develop eco-crop treatmentsAphea.Bio raised €14 million in a Series B led by Astanor Ventures to develop bio-based pesticide and herbicide alternatives. The funding will support products to reduce fertilizer use and control fungal diseases in maize and wheat.FinSMEsAphea.Bio Raises € 14M in Series B FundingAphea.Bio, a Belgian agtech startup, raised €14M in Series B funding led by Astanor Ventures. The company will use the funds to advance its biostimulant and biofungicide R&D toward regulatory submission and first product launch, and expand into bioinsecticides and bioherbicides.Nordic 9Aphea Bio announced a €14M Series B funding round was led by Astanor Ventures.Aphea Bio, a Belgian biotech, raised €14M in a Series B round led by Astanor Ventures. The funding will support its development of biostimulants and biocontrol agents for maize and wheat. The company previously raised €7.7M in 2017.AgFunderNewsWith companies like Aphea Bio & Biotalys, Ghent is Europe’s hidden gem for ag biotechAphea.Bio, a Ghent-based biotech spinoff, raised $16.6M in a Series B round led by Astanor Ventures. The funding will advance its bio-stimulant and bio-fungicide R&D and product launches. The company aims to help the EU meet its Green Deal targets for reduced fertilizer and pesticide use by 2030.AgFunderNewsAphea.Bio Raises $10m in Series A and Grant Funding for Microbial Soil TechnologyAphea.Bio, a Belgian startup spun out of VIB, raised €9 million in Series A funding and a €1.3 million R&D grant. The company will develop biopesticides and biostimulants based on natural microorganisms to improve crop yields and protect against fungal diseases. It targets staple crops like wheat, barley, and maize.FinSMEsAphea.Bio Raises €9M in FundingAphea.Bio, a Belgian sustainable agricultural products developer, raised €9M in series A funding led by V-Bio Ventures. The company will use the funds to advance its biologicals for crop yield and plant protection. It is a spin-off of VIB, UGent, and KU Leuven.